Evidence map›Paper›PMID 31594963›Full record

ArticleScientific reports2019

Normal mammary gland development after MMTV-Cre mediated conditional PAK4 gene depletion.

Parisa Rabieifar, Ting Zhuang, Tânia D F Costa, Miao Zhao, Staffan Strömblad

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Parisa RabieifarDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Ting ZhuangDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Tânia D F CostaDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-6296-5225
Miao ZhaoDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Staffan StrömbladDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. Staffan.Stromblad@ki.se.ORCID http://orcid.org/0000-0002-1236-6339
Karolinska Institutet · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p21-activated kinases (PAKs) are serine/threonine kinases functioning as downstream effectors of the small GTPases Rac1 and Cdc42. Members of the PAK family are overexpressed in human breast cancer, but their role in mammary gland development is not fully explored. Here we examined the functional role of PAK4 in mammary gland development by creating a mouse model of MMTV-Cre driven conditional PAK4 gene depletion in the mammary gland. The PAK4 conditional knock-out mice were born healthy, with no observed developmental deficits. Mammary gland whole-mounts revealed no defects in ductal formation or elongation of the mammary tree through the fat pad. PAK4 gene depletion also did not alter proliferation and invasion of the mammary epithelium in young virgin mice. Moreover, adult mice gave birth to healthy pups with normal body weight upon weaning. This implies that MMTV-Cre induced gene depletion of PAK4 in mice does not impair normal mammary gland development and thereby provides an in vivo model that can be explored for examination of the potential function of PAK4 in breast cancer.

Indexed as

AnimalsCell ProliferationCrosses, GeneticDisease Models, AnimalFemaleLitter SizeMaleMammary Glands, AnimalMammary Neoplasms, ExperimentalMice, Knockoutp21-Activated Kinasesp21-Activated KinasesPak4 protein, mouse

Identifiers

PMID31594963
PMCPMC6783434
OpenAlexW2979560111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.